These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 3891115)

  • 21. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
    Winstanley TG; Spencer RC
    Drugs Exp Clin Res; 1986; 12(12):967-71. PubMed ID: 3471432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Thabaut A; Meyran M; Chanal M; Cluzel M; Brun Y; Coulet M; Fleurette J
    Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of the combination of erythromycin with new beta-lactam antibiotics against gram-negative aerobic respiratory pathogens.
    Nakatomi M; Neu HC
    Chemioterapia; 1986 Dec; 5(6):379-84. PubMed ID: 3802298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Susceptibility of gram-negative bacilli to aminoglycosides].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Apr; 21(2):98-102. PubMed ID: 3328818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the in vitro effect of ceftazidime and 12 other antibiotics on gram-negative bacteria isolated from a hospital environment].
    Goglio A; Obiso D; Donadini C; Perani V
    G Ital Chemioter; 1984; 31(3):219-22. PubMed ID: 6442982
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation].
    Piccolomini R; Di Sipio L; Ravagnan G
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):133-9. PubMed ID: 6776969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
    Ruczkowska J; Dolna I
    Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
    Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F
    Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of new beta-lactam antibiotics].
    Cullmann W; Stieglitz M
    Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
    Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
    Wilkinson LD; Gentry LO
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():53-6. PubMed ID: 19802969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods.
    Vrbová E; Uxová M; Výmola F
    Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F; Tassi C; Stagni GR
    Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
    Lee YH; Hussain ZA; Choong FP
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):299-303. PubMed ID: 2125616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.